CIP
SPPI

Convergence Investment Partners’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Convergence Investment Partners’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-248,302
Closed -$1.49M – 400
2015
Q3 		$1.49M Buy
+248,302
New +$1.72M 0.17% 194

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Convergence Investment Partners's SPPI Position: Q4 2015 in Review

Convergence Investment Partners sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2015, closing a stake of 248,302 shares — an estimated $1.49M sold.

Convergence Investment Partners first reported a position in SPPI in Q3 2015 and held it in 1 quarter. The position peaked at $1.49M in Q3 2015. 146 funds tracked by Wall St. Rank hold SPPI as of Q4 2015.

  • Convergence Investment Partners reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Convergence Investment Partners sold 248,302 Spectrum Pharmaceuticals Inc shares in Q4 2015, an estimated $1.49M.
  • Convergence Investment Partners first reported a position in Spectrum Pharmaceuticals Inc in Q3 2015 and held it in 1 quarter.
  • Convergence Investment Partners's Spectrum Pharmaceuticals Inc position peaked at $1.49M in Q3 2015.
  • 146 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2015.

Based on Convergence Investment Partners's 13F filing for Q4 2015, filed 12 Feb 2016.